Clinical Trial Update: A Trial of "APL-9796'' in Adults With Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of APL-9796 for adults with pulmonary arterial hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• APL-9796

Snippet

Sponsor: Apollo Therapeutics Ltd | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: RECRUITING